Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.190
+0.150 (4.93%)
At close: Apr 28, 2026, 4:00 PM EDT
3.200
+0.010 (0.31%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,517,833
Market Cap
29.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Kyntra Bio | 34 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| BriaCell Therapeutics | 16 |
| Lantern Pharma | 16 |
| Apollomics | 13 |
| Neuphoria Therapeutics | 8 |
TVRD News
- 26 days ago - Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium - GlobeNewsWire
- 4 weeks ago - Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GlobeNewsWire
- 4 months ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PRNewsWire
- 4 months ago - SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - GlobeNewsWire
- 5 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PRNewsWire
- 5 months ago - Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire